Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of add-on topiramate in Lennox-Gastaut syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome
• Seizures

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Seizures | Phase 3 | Status: COMPLETED